Literature DB >> 4240219

Blood fibrinolytic activity during arvin therapy.

W R Pitney, W R Bell, G Bolton.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 4240219     DOI： 10.1111/j.1365-2141.1969.tb00389.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  The effect of angrod on the delayed hypersensitivity response in rats.

Authors:  S Silberman; H C Kwaan
Journal:  Br J Exp Pathol       Date:  1975-02

2.  Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.

Authors:  S V Pizzo; M L Schwartz; R L Hill; P A McKee
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

Review 3.  Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  Postsurgical hemorrhage in dogs anticoagulated with ancrod (Arvin).

Authors:  C L Slade; L M Taylor; A S Wechsler; P A McKee
Journal:  Ann Surg       Date:  1973-12       Impact factor: 12.969

5.  Coagulation and fibrinolysis after injury.

Authors:  P T Flute
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1970

Review 6.  Defibrinogenating enzymes.

Authors:  W R Bell
Journal:  Drugs       Date:  1997       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.